Abstract
Purpose
To compare macular atrophy (MA) secondary to age-related macular degeneration (AMD) and Stargardt disease (STGD) using the choroidal vascularity index (CVI).
Methods
In this multicentric retrospective study, two distinct cohorts were collected: patients with MA secondary to AMD and MA secondary to STGD. All patients were investigated using a multimodal imaging approach, including CVI in the subfoveal 1000 μm area. Of note, the CVI is not influenced by aging, which allows comparisons between different cohorts.
Results
Seventy eyes were included: 35 eyes of 35 patients (mean age 78 ± 7 years) in the AMD group and 35 eyes of 35 patients (mean age 41 ± 16 years, p < 0.001) in the STGD group. Choroidal thickness was significantly lower in the AMD group in comparison to the STGD group (151 ± 80 μm vs 353 ± 105 μm, p < 0.001). The total choroidal area (TCA) was significantly greater in the STGD group in comparison to the AMD group (1.734 ± 0.958 mm2 vs 0.538 ± 0.391 mm2, respectively, p < 0.001).
Interestingly, the CVI was significantly lower in AMD patients in comparison to STGD patients (27.322 ± 15.320% vs 49.880 ± 7.217%, respectively, p < 0.001), and this difference was confirmed in the subgroup of patients over 50 years old.
Conclusion
Our results corroborate the hypothesis that large choroidal vessels were impaired to a greater extent in AMD than in STGD. CVI may help in differentiating AMD from STGD in the presence of MA, better understanding of the pathogenesis, and monitoring of therapeutic response.
Similar content being viewed by others
References
Gune S, Abdelfattah NS, Karamat A et al (2020) Spectral-domain OCT-based prevalence and progression of macular atrophy in the HARBOR study for Neovascular age-related macular degeneration. Ophthalmology 127:523–532
Sacconi R, Corbelli E, Querques L et al (2017) A review of current and future management of geographic atrophy. Ophthalmol Ther 6:69–77
Bhutto I, Lutty G (2012) Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch’s membrane/choriocapillaris complex. Mol Asp Med 33:295–317
Querques G, Bandello F, Sacconi R et al (2017) Recent advances in the management of dry age-related macular degeneration: a review. F1000Res 6:245
Sacconi R, Corbelli E, Borrelli E et al (2021) Choriocapillaris flow impairment could predict the enlargement of geographic atrophy lesion. Br J Ophthalmol 105:97–102
Sacconi R, Corbelli E, Carnevali A et al (2018) Optical coherence tomography angiography in geographic atrophy. Retina 38:2350–2355
Corbelli E, Sacconi R, Rabiolo A et al (2017) Optical coherence tomography angiography in the evaluation of geographic atrophy area extension. Invest Ophthalmol Vis Sci 58:5201–5208
Cideciyan AV, Aleman TS, Swider M et al (2004) Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum Mol Genet 13:525–534
Mata NL, Weng J, Travis GH (2000) Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration. Proc Natl Acad Sci U S A 97:7154–7159
Klevering BJ, Deutman AF, Maugeri A et al (2005) The spectrum of retinal phenotypes caused by mutations in the ABCA4 gene. Graefes Arch Clin Exp Ophthalmol 243:90–100
Wang DL, Agee J, Mazzola M et al (2019) Outer retinal thickness and fundus autofluorescence in geographic atrophy. Ophthalmol Retin 3:1035–1044
Fish G, Grey R, Sehmi KS, Bird AC (1981) The dark choroid in posterior retinal dystrophies. Br J Ophthalmol 65:359–363
Giani A, Pellegrini M, Carini E et al (2012) The dark atrophy with indocyanine green angiography in stargardt disease. Investig Ophthalmol Vis Sci 53:3999–4004
Pellegrini M, Acquistapace A, Oldani M et al (2016) Dark atrophy: an optical coherence tomography angiography study. Ophthalmology 123:1879–1886
Zhou H, Dai Y, Shi Y et al (2020) Age-related changes in choroidal thickness and the volume of vessels and stroma using swept-source OCT and fully automated algorithms. Ophthalmol Retin 4:204–215
Agrawal R, Gupta P, Tan KA, Cheung CM, Wong TY, Cheng CY (2016) Choroidal vascularity index as a measure of vascular status of the choroid: measurements in healthy eyes from a population-based study. Sci Rep 6:21090
Goud A, Singh SR, Sahoo NK et al (2019) New insights on choroidal vascularity: a comprehensive topographic approach. Invest Ophthalmol Vis Sci 60:3563–3569
Koçak N, Subaşı M, Yeter V (2021) Effects of age and binarising area on choroidal vascularity index in healthy eyes: an optical coherence tomography study. Int Ophthalmol 41:825–834
Nivison-Smith L, Khandelwal N, Tong J, Mahajan S, Kalloniatis M, Agrawal R (2020) Normal aging changes in the choroidal angioarchitecture of the macula. Sci Rep 10:10810
Breher K, Terry L, Bower T, Wahl S (2020) Choroidal biomarkers: a repeatability and topographical comparison of choroidal thickness and choroidal vascularity index in healthy eyes. Transl Vis Sci Technol 9(11):8
Fishman GA, Stone EM, Grover S et al (1999) Variation of clinical expression in patients with Stargardt dystrophy and sequence variations in the ABCR gene. Arch Ophthalmol 117:504–510
Sonoda S, Sakamoto T, Yamashita T et al (2015) Luminal and stromal areas of choroid determined by binarization method of optical coherence tomographic images. Am J Ophthalmol 159:1123-1131.e1
Sonoda S, Sakamoto T, Yamashita T et al (2014) Choroidal structure in normal eyes and after photodynamic therapy determined by binarization of optical coherence tomographic images. Investig Ophthalmol Vis Sci 55:3893–3898
Agrawal R, Wei X, Goud A, Vupparaboina KK, Jana S, Chhablani J (2017) Influence of scanning area on choroidal vascularity index measurement using optical coherence tomography. Acta Ophthalmol 95:e770–e775
Battaglia Parodi M, Sacconi R, Romano F, Bandello F (2019) Hyperreflective foci in Stargardt disease: 1-year follow-up. Graefes Arch Clin Exp Ophthalmol 257:41–48
Schwoerer J, Secrétan M, Zografos L, Piguet B (2000) Indocyanine green angiography in fundus flavimaculatus. Ophthalmologica 214:240–245
Iovino C, Pellegrini M, Bernabei F et al (2020) Choroidal vascularity index: an in-depth analysis of this novel optical coherence tomography parameter. J Clin Med 9:595
Iovino C, Au A, Hilely A et al (2019) Evaluation of the choroid in eyes with retinitis Pigmentosa and cystoid macular edema. Invest Ophthalmol Vis Sci 60:5000–5006
Rizzo S, Savastano A, Finocchio L et al (2018) Choroidal vascularity index changes after vitreomacular surgery. Acta Ophthalmol 96:e950–e955
Wei X, Mishra C, Kannan NB et al (2019) Choroidal structural analysis and vascularity index in retinal dystrophies. Acta Ophthalmol 97:e116–e121
Wei X, Ting DSW, Ng WY, Khandelwal N, Agrawal R, Cheung CMG (2017) Choroidal vascularity index: a novel optical coherence tomography based parameter in patients with exudative age-related macular degeneration. Retina 37:1120–1125
Giannaccare G, Pellegrini M, Sebastiani S et al (2020) Choroidal vascularity index quantification in geographic atrophy using BINARIZATION of enhanced-depth imaging optical coherence tomographic scans. Retina 40:960–965
Ratra D, Tan R, Jaishankar D et al (2018) Choroidal structural changes and vascularity index in STARGARDT disease on swept source optical coherence tomography. Retina 38:2395–2400
MacHalińska A, Kawa MP, Marlicz W, MacHaliński B (2012) Complement system activation and endothelial dysfunction in patients with age-related macular degeneration (AMD): possible relationship between AMD and atherosclerosis. Acta Opthalmol 90:695–703
Nunes RP, Rosa PR, Giani A et al (2015) Choroidal thickness in eyes with central geographic atrophy secondary to stargardt disease and age-related macular degeneration. Ophthalmic Surg Lasers Imaging Retin 46:814–822
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Potential conflicts
The authors have no proprietary/financial interest regarding the publication of this study.
Eleonora Corbelli, Marco Battista, Daniela Bacherini, Alexandra Miere, Eliana Costanzo, Giovanna Vella, Lucia Ziccardi, Andrea Sodi and Stanislao Rizzo have nothing to disclose.
Riccardo Sacconi reports personal fees from Novartis (Basel, Switzerland), Zeiss (Dublin, USA) outside the submitted work.
Enrico Borrelli reports personal fees from Novartis (Basel, Switzerland), Zeiss (Dublin, USA) outside the submitted work.
Mariacristina Parravano reports personal fees from Allergan Inc. (Irvine, California,USA), Bayer Shering-Pharma (Berlin, Germany), Novartis (Basel, Switzerland), Zeiss (Dublin, USA) outside the submitted work.
Eric Souied reports personal fees from Allergan Inc. (Irvine, California,USA), Bayer Shering-Pharma (Berlin, Germany), Novartis (Basel, Switzerland), Roche (Basel, Switzerland) outside the submitted work.
Francesco Bandello reports personal fees from Alcon (Fort Worth,Texas,USA), Alimera Sciences (Alpharetta, Georgia, USA), Allergan Inc. (Irvine, California,USA), Farmila-Thea (Clermont-Ferrand, France), Bayer Shering-Pharma (Berlin, Germany), Bausch And Lomb (Rochester, New York, USA), Genentech (San Francisco, California, USA), Hoffmann-La-Roche (Basel, Switzerland), NovagaliPharma (Évry, France), Novartis (Basel, Switzerland), Sanofi-Aventis (Paris, France), Thrombogenics (Heverlee,Belgium), Zeiss (Dublin, USA) outside the submitted work.
Giuseppe Querques reports personal fees from Alimera Sciences (Alpharetta, Georgia, USA), Allergan Inc. (Irvine, California,USA), Amgen (Thousand Oaks, USA), Heidelberg (Germany), KBH (Chengdu, China), LEH Pharma (London, UK), Lumithera (Poulsbo, USA), Novartis (Basel, Switzerland), Bayer Shering-Pharma (Berlin, Germany), Sandoz (Berlin, Germany), Sifi (Catania, Italy), Soof-Fidia (Albano, Italy), Zeiss (Dublin, USA) outside the submitted work.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the San Raffaelle Ethics Committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Corbelli, E., Sacconi, R., Battista, M. et al. Choroidal vascularity index in eyes with central macular atrophy secondary to age-related macular degeneration and Stargardt disease. Graefes Arch Clin Exp Ophthalmol 260, 1525–1534 (2022). https://doi.org/10.1007/s00417-021-05337-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-021-05337-3